Twenty-seven people in Puerto Rico indicted in misbranded and diverted drug case, CBP seized counterfeit and misbranded drugs in two states, and fake arthritis and cancer medications seized in India.
Read MorePSM commissioned a survey about compounded diabetes and weight loss injectable drugs. 1,000 likely voters across political affiliations were crystal clear — they are worried about safety and the current lack of oversight. See the full results.
Read MoreThe Federal Trade Commission issued an administrative complaint against the three largest pharmacy benefit managers, alleging that the companies used their market power to inflate the cost of insulin for U.S. patients.
Read MoreIf used chronically at the recommended dose, dexamethasone could cause severe and serious adverse events such as adrenal suppression (a disorder in which the adrenal glands do not produce enough hormones), central nervous system and psychiatric/behavioral effects, weight gain, gastrointestinal effects, elevated blood glucose, increased infection risks, neuromuscular and skeletal side effects, ocular effects, cardiovascular effects, dermatologic effects endocrine and metabolic issues, among other adverse events not mentioned.
Read MoreRxeed’s suit of CVS Caremark alleges predatory practices against independent pharmacies. Walgreens joins up with NABP’s Pulse. Stories about medicine safety in the U.S. and around the world.
Read MoreReuters writes about fake Ozempic and medicine tracking. The U.S. FDA issues warnings about supplements that contain undeclared prescription medicine. Additional news in India and Nigeria.
Read MoreGuilty pleas in two federal cases involving dangerous medicines. Pill press news in South Carolina. Additional news in the U.K., India and Pakistan.
Read MoreResearchers have found pentobarbital in counterfeit prescription pills. Plus, domestic and international news, and what our executive director is reading this week.
Read MoreThis is a reprint of an FDA Alert. Boulla LLC Issues Voluntary Nationwide Recall of Boom Max Capsules Due to the Potential Presence of Undeclared Sildenafil When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or…
Read MoreA whistleblower complaint alleges that counterfeit and misbranded diabetes medical devices were being sold by third-party vendor on Amazon and orders were fulfilled by Amazon.com itself.
Read More